|
Medical diagnostic reagents and equipment are used to perform diagnostic tests in hospitals, commercial laboratories, physicians’ offices and blood banks. Reagents are an essential component of any healthcare regime, indispensable in preventing sickness, detecting and diagnosing diseases, ascertaining the side effects of drug therapy, monitoring treatment, improving patient quality of life and decreasing total healthcare costs. Repeated cuts to reimbursement prices have reduced pricing levels in Japan below those of comparable overseas markets. The current regulatory structure and reimbursement regime constitute an obstacle to introducing new products the Japanese market and the committee aims to overcome these problems.
View Issues and Recommendations – (English | Japanese) - UpdatedChairman: Dr. Isao Ikeda Representative Director & Chairman of the Board and President, Abbott Japan Co., Ltd. Roppongi First Bldg. 4F. 1-9-9 Roppongi Minato-ku, Tokyo 106-8535 Tel: +81-3-3589-9600 | Fax: +81-3-3589-9404 Members: Abbott Japan Co., Ltd Ortho-Clinical Diagnostic K.K. Roche Diagnostics K.K. SML KK Sysmex bioMerieux Co., Ltd. Upcoming Committee Meeting Schedule:
Please contact the EBC ( This e-mail address is being protected from spambots. You need JavaScript enabled to view it ) to confirm the meeting location prior to attending
- Updated on: 2011-03-03
|